Fire-district
Ocala/Marion County Fire Rescue
Ocala/Marion County Fire Rescue (Ocala, FL) carries 56 drugs across 188 dose entries in its current published protocol, effective 2021-06-01.
The current listed document is more than 24 months old and may be outdated.
Drugs and doses56
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 30 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | page 30 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | NEB | not captured | standing | page 18 |
| Anaphylaxis | peds | 2.5 mg | NEB | not captured | standing | page 18 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 53 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 53 |
| COPD | adult | 2.5 mg | NEB | not captured | standing | page 53 |
| COPD | peds | 2.5 mg | NEB | not captured | standing | page 53 |
| Hyperkalemia | adult | 5–10 mg | NEB | not captured | standing | page 38 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | page 22 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | page 22 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 30 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 32 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5 mg | IV | not captured | standing | page 28 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | page 28 |
| Organophosphate poisoning | adult | 1–2 mg | IV | not captured | standing | page 49 |
| RSI induction | peds | 0.02 mg/kg | IV | not captured | standing | page 130 |
Bumetanide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 1 mg | IV | not captured | standing | page 221 |
| Other | adult | 1 mg | IV | not captured | standing | page 221 |
| Other | adult | 1 mg | IV | not captured | standing | page 221 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 g | IV | not captured | standing | page 38 |
| Other | adult | 1 g | IV/IO | not captured | standing | page 49 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 4–24 mg | IV | not captured | standing | page 223 |
| Anaphylaxis | peds | 0.2–0.5 mg/kg | IV | not captured | standing | page 223 |
| Asthma / bronchospasm | adult | 4–24 mg | IV | not captured | standing | page 223 |
| Asthma / bronchospasm | peds | 0.2–0.5 mg/kg | IV | not captured | standing | page 223 |
| COPD | adult | 4–24 mg | IV | not captured | standing | page 223 |
| COPD | peds | 0.2–0.5 mg/kg | IV | not captured | standing | page 223 |
| Other | adult | 4–24 mg | IV | not captured | standing | page 223 |
| Other | peds | 0.2–0.5 mg/kg | IV | not captured | standing | page 223 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | D50 | IV/IO | not captured | standing | page 20 |
| Cardiac arrest | peds | D25 | IV/IO | not captured | standing | page 20 |
| Hypoglycemia | adult | 100 mL | IV/IO | not captured | standing | page 16 |
| Hypoglycemia | peds | 2 mL/kg | IV/IO | not captured | standing | page 16 |
| Other | adult | 100 mL | IV/IO | not captured | standing | page 16 |
| Other | peds | 2 mL/kg | IV/IO | not captured | standing | page 16 |
| Post-ROSC care | adult | 12.5 g | IV/IO | not captured | standing | page 26 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–4 mg | IV/IM | not captured | standing | page 17 |
| Procedural sedation | adult | 2–4 mg | IV/IM | not captured | standing | page 12 |
| Seizure | adult | 2–4 mg | IV/IO/IM | not captured | standing | page 58 |
| Seizure | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | page 58 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 10 mg | IV | not captured | standing | page 30 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 1 mg/kg | IV/IM | not captured | standing | page 18 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | page 18 |
| Hyperactive delirium | adult | 50 mg | IV/IM | not captured | standing | page 35 |
| Nausea / vomiting | adult | 25–50 mg | IV/IM | not captured | standing | page 44 |
| Other | adult | 25–50 mg | IV/IM | not captured | standing | page 37 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 28 |
| Cardiac arrest | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 24 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 24 |
| Post-ROSC care | adult | 10–20 mcg/kg | IV/IO | not captured | standing | page 26 |
| Sepsis | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 60 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IV | not captured | standing | page 18 |
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 18 |
| Anaphylaxis | peds | 0.01 mg/kg | IV | not captured | standing | page 18 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 18 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | page 53 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 53 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | page 28 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 28 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 21 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 21 |
Esmolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 500 mcg/kg | IV | not captured | standing | page 33 |
| ACS / chest pain | peds | 500 mcg/kg | IV | not captured | standing | page 33 |
| Other | adult | 500 mcg/kg | IV | not captured | standing | page 14 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 130 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 130 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 25–100 mcg | IV/IO | not captured | standing | page 11 |
| Mild to moderate pain | adult | 25–100 mcg | IM | not captured | standing | page 11 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO | not captured | standing | page 11 |
Fosphenytoin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Status epilepticus | adult | 15–20 mg/kg | IV | not captured | standing | page 234 |
| Status epilepticus | adult | 15–20 mg/kg | IM | not captured | standing | page 234 |
| Status epilepticus | peds | 15–20 mg/kg | IV | not captured | standing | page 234 |
| Status epilepticus | peds | 15–20 mg/kg | IM | not captured | standing | page 234 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 3–5 mg | IV/IO/IM | not captured | standing | page 49 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 235 |
| Hypoglycemia | peds | 0.5 mg | IM | not captured | standing | page 235 |
Heparin Sodium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 60–80 unit/kg | IV | not captured | standing | page 236 |
| ACS / chest pain | peds | 50 unit/kg | IV | not captured | standing | page 236 |
Hydralazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 5–10 mg | IV | not captured | standing | page 47 |
| Other | adult | 20–40 mg | IV | not captured | standing | page 237 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1 mg | IV/IM | not captured | standing | page 12 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 239 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 53 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 53 |
| COPD | adult | 0.5 mg | NEB | not captured | standing | page 53 |
| COPD | peds | 0.5 mg | NEB | not captured | standing | page 53 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | page 35 |
| Mild to moderate pain | adult | 0.5 mg/kg | IM | not captured | standing | page 74 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.2 mg/kg | IV/IO | not captured | standing | page 277 |
| Other | adult | 10 mg | IV | not captured | standing | page 277 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IO | not captured | standing | page 166 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 166 |
| RSI induction | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 130 |
| RSI induction | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 130 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg | IV/IM | not captured | standing | page 17 |
| Procedural sedation | adult | 1 mg | IV/IM | not captured | standing | page 12 |
| Seizure | adult | 1 mg | IV/IM | not captured | standing | page 58 |
| Seizure | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 58 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 1–2 g | IV | not captured | standing | page 53 |
| Cardiac arrest | adult | 2 g | IV/IO | not captured | standing | page 22 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 47 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 248 |
Mannitol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | peds | 0.5–1 g/kg | IV | not captured | standing | page 249 |
| Other | adult | 0.25–0.5 g/kg | IV | not captured | standing | page 249 |
| Other | adult | 0.25–0.5 g/kg | IV | not captured | standing | page 249 |
| Other | adult | 0.25–0.5 g/kg | IV | not captured | standing | page 249 |
| Other | peds | 0.5–1 g/kg | IV | not captured | standing | page 249 |
| Other | peds | 0.5–1 g/kg | IV | not captured | standing | page 249 |
| Other | peds | 0.5–1 g/kg | IV | not captured | standing | page 249 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV | not captured | standing | page 15 |
| Anaphylaxis | adult | 125 mg | IV | not captured | standing | page 18 |
| Anaphylaxis | peds | 2 mg/kg | IV | not captured | standing | page 18 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | page 53 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV | not captured | standing | page 53 |
| COPD | adult | 125 mg | IV | not captured | standing | page 53 |
| COPD | peds | 2 mg/kg | IV | not captured | standing | page 53 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 5 mg | IV/IO | not captured | standing | page 32 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–4 mg | IV/IM | not captured | standing | page 17 |
| Other | adult | 2–4 mg | IV/IM | not captured | standing | page 158 |
| Procedural sedation | adult | 2–4 mg | IV/IM | not captured | standing | page 12 |
| RSI induction | adult | 2–4 mg | IV | not captured | standing | page 122 |
| RSI induction | peds | 0.05–0.1 mg/kg | IV | not captured | standing | page 122 |
| Seizure | adult | 2–4 mg | IV/IM | not captured | standing | page 58 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 2 mg | IV | not captured | standing | page 56 |
| Mild to moderate pain | adult | 2 mg | IV | not captured | standing | page 12 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV | not captured | standing | page 12 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 20 |
| Other | adult | 0.4 mg | IV/IO | not captured | standing | page 16 |
| Other | adult | 0.4 mg | IV/IO | not captured | standing | page 49 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 16 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 49 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 1 auto-injector | IM | not captured | standing | page 220 |
Nicardipine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stroke | adult | 5 mg | IV | not captured | standing | page 65 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 32 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 55 |
| CHF / pulmonary edema | adult | 1 inch | TOP | not captured | standing | page 55 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 13 |
| Nausea / vomiting | adult | 4 mg | SL | not captured | standing | page 44 |
| Nausea / vomiting | peds | 0.2 mg/kg | IV/IM | not captured | standing | page 13 |
| Mild to moderate pain | adult | 4 mg | IV | not captured | standing | page 11 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 16 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | page 16 |
Phenobarbital
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 10–20 mg/kg | IV | not captured | standing | page 266 |
| Status epilepticus | adult | 10–20 mg/kg | IV | not captured | standing | page 266 |
| Status epilepticus | peds | 5–20 mg/kg | IV | not captured | standing | page 266 |
Phenylephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 50 mcg | IV | not captured | standing | page 267 |
| Cardiogenic shock | peds | 0.1–0.5 mcg/kg | IV | not captured | standing | page 267 |
| Hypotension / shock | adult | 50 mcg | IV | not captured | standing | page 267 |
| Hypotension / shock | adult | 50 mcg | IV | not captured | standing | page 267 |
| Hypotension / shock | peds | 0.1–0.5 mcg/kg | IV | not captured | standing | page 267 |
| Hypotension / shock | peds | 0.1–0.5 mcg/kg | IV | not captured | standing | page 267 |
Phenytoin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15–20 mg/kg | IV | not captured | standing | page 268 |
| Other | peds | 15–20 mg/kg | IV | not captured | standing | page 268 |
| Seizure | adult | 15–20 mg/kg | IV | not captured | standing | page 268 |
| Seizure | peds | 15–20 mg/kg | IV | not captured | standing | page 268 |
| Status epilepticus | adult | 15–20 mg/kg | IV | not captured | standing | page 268 |
| Status epilepticus | peds | 15–20 mg/kg | IV | not captured | standing | page 268 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IV | not captured | standing | page 44 |
| Mild to moderate pain | adult | 12.5 mg | IV | not captured | standing | page 13 |
Propofol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100–150 mcg/kg | IV | not captured | standing | page 269 |
| Other | peds | 5 mcg/kg | IV | not captured | standing | page 269 |
| RSI induction | adult | 2–2.5 mg/kg | IV | not captured | standing | page 269 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | page 122 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | page 122 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | page 20 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | page 20 |
| Hyperkalemia | adult | 50 mEq | IV | not captured | standing | page 38 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | page 49 |
Sodium Nitroprusside
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 0.5–10 mcg/kg | IV | not captured | standing | page 260 |
| Other | adult | 0.5–10 mcg/kg | IV | not captured | standing | page 260 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1–1.5 mg/kg | IV | not captured | standing | page 130 |
| RSI induction | peds | 1–1.5 mg/kg | IV | not captured | standing | page 130 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.25 mg | SQ | not captured | standing | page 273 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 drop | not captured | not captured | standing | page 76 |
| Other | peds | 1 drop | not captured | not captured | standing | page 76 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IM | not captured | standing | page 275 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 275 |
Tissue Plasminogen Activator
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 100 mg | IV | not captured | standing | page 276 |
| Other | adult | 100 mg | IV | not captured | standing | page 276 |
| Other | adult | 100 mg | IV | not captured | standing | page 276 |
| Other | adult | 100 mg | IV | not captured | standing | page 276 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 278 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 40 International Units | IV/IO | not captured | standing | page 279 |
| VF / pulseless VT | adult | 40 International Units | IV/IO | not captured | standing | page 279 |
| VF / pulseless VT | adult | 40 International Units | IV/IO | not captured | standing | page 279 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.05–0.1 mg/kg | IV/IO | not captured | standing | page 122 |
| RSI induction | peds | 0.05–0.1 mg/kg | IV/IO | not captured | standing | page 122 |